Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Medivir Ab
Medivir Ab_20100107

Medivir Ab patents


Recent patent applications related to Medivir Ab. Medivir Ab is listed as an Agent/Assignee. Note: Medivir Ab may have other listings under different names/spellings. We're not affiliated with Medivir Ab, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "M" | Medivir Ab-related inventors


Nucleotide phosphoramidate formulation

is an HCV antiviral protide, which is surprisingly soluble in ethanol, thereby facilitating the preparation of pharmaceutical formulations, such as adsorbed mesoporous carriers or SEDDS of Pouton Types III or IV.... Medivir Ab

Protease inhibitors

or a pharmaceutically acceptable salt, N-oxide or hydrate thereof, have utility in the treatment of disorders characterized by inappropriate expression or activation of cathepsin K, such as osteoporosis, osteoarthritis, rheumatoid arthritis or bone metastases.... Medivir Ab

Methods for the preparation of diastereomerically pure phosphoramidate prodrugs

Methods for the preparation of diastereomerically pure phosphoramidate prodrugs of nucleosides, and intermediates useful for the preparation are provided. The nucleosides are useful for the treatment of hepatitis C and cancer.... Medivir Ab

Dioxolane analogues of uridine for the treatment of cancer

which are of use in the treatment of cancer, and related aspects.... Medivir Ab

Macrocyclic inhibitors of hepatitis c virus

pharmaceutical compositions containing compounds (I) and processes for preparing compounds (I). Bioavailable combinations of the inhibitors of HCV of formula (I) with ritonavir are also provided.... Medivir Ab

Hcv ns-3 serine protease inhibitors

Methods drawn to peptidomimetic compounds which inhibit the NS3 protease of the hepatitis C virus (HCV), are described. The compounds have the formula (VI) where the variable definitions are as provided in the specification. The compounds comprise a carbocyclic P2 unit in conjunction with a novel linkage to those portions... Medivir Ab

Protease inhibitors

or a pharmaceutically acceptable salt, N-oxide or hydrate thereof, have utility in the treatment of disorders characterized by inappropriate expression or activation of cathepsin K, such as osteoporosis, osteoarthritis, rheumatoid arthritis or bone metastases:... Medivir Ab

Treatment of chagas disease

The invention provides compounds of the formula: wherein L1 and L2 are independently selected from O and S; R1 is C3-C6 straight or branched alkyl, C3-C7cycloalkyl, C5-C7cycloalkenyl, adamantly, phenyl or saturated heterocyclyl, any of which being optionally substituted; R2 is H, methyl or ethyl; R5 is NRxCORy, NRxRy, CH2COCH3, CH2C≡N,... Medivir Ab

Hcv polymerase inhibitors

which are of use in the treatment or prophylaxis of hepatitis C virus infection, and related aspects.... Medivir Ab








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Medivir Ab in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Medivir Ab with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###